Skip to content

#Commerce/ITA

0 items today
Sep 28Mon
  1. CBP · CSMS

    CBP issues updated Section 232 guidance on pharmaceutical imports under Proclamation 11020

    CBP states in CSMS # 70054007 that updated guidance covers Section 232 duties on pharmaceutical articles and ingredients under Proclamation 11020 and the September 23, 2026 Federal Register notice (91 FR 60360), with duties effective July 31, 2026 for Annex III companies and September 29, 2026 for all other companies. Entries use HTSUS headings 9903.04.60–9903.04.70, including 100% for patented articles under 9903.04.60, 15% for Japan, EU member countries, South Korea, Switzerland and Liechtenstein under 9903.04.62, and 0% for the United Kingdom under 9903.04.63. The notice makes five technical corrections to Annex I and one to Annex IV, removing 2937.23.50, 3002.13.00, 3002.14.00, 3002.15.00 and 3004.49.00 from Annex IV.

Sep 22Tue
  1. CBP · CSMS

    CBP issues guidance on polysilicon import ban under Proclamation 11052

    CBP states in CSMS # 69994928 that, under Commerce's Temporary Final Rule implementing Proclamation 11052 (91 FR 51975), an importer of record that Commerce determines is importing polysilicon products in volumes substantially greater than its historic averages, or that a new importer of record is exceeding applicable weekly quantity limits, is prohibited from making further entries of certain polysilicon products until December 4, 2026. The goods may be moved to a bonded warehouse but may not be entered for consumption before that date. Affected importers may apply to Commerce to waive the prohibition.